Posted on 05/02/2023 8:15:00 AM PDT by Red Badger
Pfizer’s revenue dropped in the first quarter of 2023 primarily due to flagging COVID-19 vaccine sales.
The company reported $18.3 billion in revenue, down from $25.6 billion in the first quarter of 2022. Pfizer made just $7.1 billion from its COVID-19 vaccines and the COVID-19 pill after reaping more than $56 billion from the products in 2022.
The drop in COVID-19 product sales was expected, company officials said.
As Pfizer CEO Albert Bourla was expected to tell investors in an earnings call: “Our financial results were as we anticipated. Our non-COVID revenues grew 5 percent operationally compared with the year-ago quarter, while overall revenues declined 26 percent operationally primarily due to a previously communicated and expected decline in Comirnaty revenues.”
Pfizer and other COVID-19 vaccine manufacturers have been dealing with decreased demand amid plunging effectiveness and lower levels of COVID-19 in various countries. The company said in its 2022 report that it could not “accurately predict the impact of COVID-19 on our business” and that various factors could affect sales, including an inability to report clinical trial results for its updated COVID-19 vaccine.
Pfizer expects 65 million COVID-19 doses to be administered in 2023, down from 92 million in 2022. But the company projects an increase to 67 million in 2024. And if a planned combination COVID-19/influenza shot works out, officials project the administration of 77 million doses in 2025 and 98 million doses in 2026.
“In terms of our COVID products—Comirnaty and Paxlovid—we expect sales to trend more seasonally in 2023,” Dr. Mikael Dolsten, Pfizer’s chief scientific officer, planned to tell investors. “Given these dynamics, we expect significantly lower sales contributions from our COVID products in the second quarter versus the first quarter.”
Pfizer officials, however, predict that sales will pick up if U.S. regulators follow through on plans to update the vaccine strains to target the variants in circulation.
Current plans involve picking the strain or strains to target in the spring or summer and rolling out updated shots each year during the fall, similar to how influenza vaccines are distributed in some countries.
The market for both the vaccines and Paxlovid, Pfizer’s COVID-19 pill, are shifting from largely government-driven to commercial this year as governments stop buying or slow down the purchasing of COVID-19 products from companies like Pfizer.
“We continue to expect 2023 to be a transition year as the virus continues to mutate and we move from advance purchases under government contracts to more traditional supply arrangements in a commercial model for both Comirnaty and Paxlovid in the U.S,” Bourla’s prepared remarks stated.
The company expects to make $67–71 billion in 2023. It made $100.3 billion in 2022.
Moderna, Pfizer’s chief rival for COVID-19 vaccines, is slated to report its first-quarter results on May 4. Moderna reported $5.1 billion in COVID-19 vaccine sales in the fourth quarter of 2022, down from $7.2 billion in the fourth quarter of 2021, and expects declining sales in 2023.
Novavax, another COVID-19 vaccine maker, is at risk of shutting down due to uncertainty around its revenue in 2023, while Johnson & Johnson’s COVID-19 vaccine is also authorized in the United States but has been deemphasized due to its link to a deadly blood-clotting condition.
“ if a planned combination COVID-19/influenza shot works out”
That is alarming. I hope they don’t remove the influenza alone shot from the market
Never fear, they have already conjured up a mRNA Marburg “fake Vax” for the already appearing in Africa relative of Ebola, Marburg virus.
They will remove the flu alone shot because the whole purpose in combining them is so you have to take the covid shot if you want the flu shot.
I plan on taking none of them.
Pfizer- for all those revenues from these “products” had NO:
Liability exposure under the EUA for most of the forced application of the “vaccines” (which are not and never have been vaccines).
No investment in the creation of the “vaccines”. US govt. subsidized the entire formulation, manufacture and even distribution. Pfizer was out ZERO dollars.
The 56 billion is therefore pure profit with no liabilities or expenses other than their labor expense which is deducted in the full corporate statements for worldwide employees. With the exception of Executive Compensation which is exempt salary plus bookoodles bonus and benefits- mined from the employee individual insurance which the company takes out on each employee. Complete cost shifting.
Whaaaaa, wahhh, whaaaa goes the whine. In reality they cashed in and continued their “partnership” with Government entities who are NOT under legal exposure what so ever.
Criminal globalists who GOT IT WRONG!!
they knowingly plotted genocide and sterilization
and cancer for billions of people.
the majority of their victim’s families think that
they dont deserve oxygen.
I had heard, a year ago or more, that they were thinking of making all of the flu vaccines MRNA, like the COVID shots. I decided then that I was done taking flu shots. I do not trust these shots; and, I don't think I am alone.
Never go back, folks. AB needs to fail completely.
So I looked up flu shot distribution for past 20 years. It looks like starting in about 2010, 50% of Americans got the annual flu shot. CDC says on their website that flu shot effectiveness ranges from 28-48% per year. Actually a few years were over 50% and there were as many in the LOW TEENS for effectiveness. https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates.html
So with a track record of marginal effectiveness at best for over 20 years how would any “new” shots be any better? I know annual flu shot formulation is a guess at best, but one would think that after 20 years they would would be able to guess better.
If they could string together say 5 years of 85% effective then maybe I would consider. But if it’s a Pfizer product, then they can go to hell!!!
This news sure seems to contradict this propaganda from The Hill.
https://freerepublic.com/focus/f-news/4149878/posts
Who told you that? It's wrong.
Pfizer refused any Warp Speed money for development or production and funded it themselves.
All they got from the government was a purchase agreement where we guaranteed to buy 300 million doses if Pfizer was successful in developing a vaccine and getting it approved.
Moderna and some other firms did take Warp Speed money for development, but not Pfizer.
So here's a simple question. If the pandemic is officially announced as over, are the "COVID-19 vaccine" shots now subject to product liability laws and examination?
Additionally....
If there is no longer an "emergency," how is an "emergency use authorization" supported or supportable? And if the "emergency use authorization" is continued by the Biden administration without an "emergency," why?
18 billion. Not a bad haul.
You could get it too. All you have to do is produce 300M doses of a Covid vaccine and get it approved. You'll be on Easy Street.
Flu and covid shots are required by CMS. There is a false demand.
well
their number one salesman
did retire
maybe fauci wants to come out of retirement
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.